Replies to post #14189 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Index to Posts on Pharming

[Updated for 3Q08 results.]


Rhucin:
#msg-30791896 Regulatory update on Rhucin (9/22/08)
#msg-30035067 Phase-3 Rhucin data (US)
#msg-22482530 Pharming seeks US Rhucin partner
#msg-22208171 Phase-3 Rhucin data (Europe)
#msg-27808107 EMEA rejects Rhucin re-examination
#msg-30621194 Rhucin open-label extension studies

Intellectual property:
#msg-30659059 Musings on a GTC-Pharming merger
#msg-18949245 IP cross-license with GTC
#msg-27220955 Pharming licenses cattle IP from ACTC

Financial and general:
#msg-32927640 3Q08 financial results
#msg-30659059 Notes on Pharming’s debt load
#msg-32444826 New CEO named
#msg-28738755 New program in “aging”